Structural characterization of dimethyldithiodenafil and dimethylthiocarbodenafil, analogs of sildenafil


    loading  Checking for direct PDF access through Ovid

Abstract

HighlightsDimethyldithiodenafil and dimethylthiocarbodenafil were detected in three powder products.Dimethyldithiodenafil and dimethylthiocarbodenafil were established using HRMS and NMR.Dimethyldithiodenafil was subjected to an X-ray structural analysis and PDE assay.Three powder products contained 12–19 mg dimethyldithiodenafil per tube.Three powder products contained 1.4–3.9 mg dimethylthiocarbodenafil per tube.Two analogs of sildenafil (compounds 1 and 2) were detected in three powder products acquired from online drug markets during an LC–UV–MS analysis of psychotropic drugs. Their structures were established by high-resolution mass spectrometry and NMR spectroscopy. Compound 1 was identified as 5-(5-(3,5-dimethylpiperazine-1-carbonothioyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-thione and named dimethyldithiodenafil. Compound 2 was identified as 5-(5-(3,5-dimethylpiperazine-1-carbonothioyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one and named dimethylthiocarbodenafil. Compound 1 was subjected to the phosphodiesterase assay (IC50 = 0.20 nM). The three powder products were found to contain 12–19 mg of dimethyldithiodenafil and 1.4–3.9 mg of dimethylthiocarbodenafil per tube.

    loading  Loading Related Articles